Correlation Between Boston Scientific and CG Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boston Scientific and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Scientific and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boston Scientific Corp and CG Oncology, Common, you can compare the effects of market volatilities on Boston Scientific and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Scientific with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Scientific and CG Oncology,.

Diversification Opportunities for Boston Scientific and CG Oncology,

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Boston and CGON is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Boston Scientific Corp and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and Boston Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Scientific Corp are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of Boston Scientific i.e., Boston Scientific and CG Oncology, go up and down completely randomly.

Pair Corralation between Boston Scientific and CG Oncology,

Considering the 90-day investment horizon Boston Scientific Corp is expected to generate 0.36 times more return on investment than CG Oncology,. However, Boston Scientific Corp is 2.8 times less risky than CG Oncology,. It trades about 0.18 of its potential returns per unit of risk. CG Oncology, Common is currently generating about 0.0 per unit of risk. If you would invest  8,114  in Boston Scientific Corp on September 3, 2024 and sell it today you would earn a total of  952.00  from holding Boston Scientific Corp or generate 11.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Boston Scientific Corp  vs.  CG Oncology, Common

 Performance 
       Timeline  
Boston Scientific Corp 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Boston Scientific may actually be approaching a critical reversion point that can send shares even higher in January 2025.
CG Oncology, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CG Oncology, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, CG Oncology, is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Boston Scientific and CG Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boston Scientific and CG Oncology,

The main advantage of trading using opposite Boston Scientific and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Scientific position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.
The idea behind Boston Scientific Corp and CG Oncology, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators